Last reviewed: June 24, 2026
Last updated: June 24, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide and similar GLP-1 medications work by slowing stomach emptying and reducing appetite signals in the brain, but they can also affect cardiovascular function. If you have low blood pressure, taking a GLP-1 drug requires careful medical evaluation and monitoring. PlexusDx provides personalized semaglutide therapy with genetic insights to help identify how your body may respond to treatment.
How GLP-1 Medications Affect Blood Pressure
GLP-1 receptor agonists activate receptors throughout the body, including in blood vessels and the heart. In clinical trials, semaglutide and tirzepatide lowered systolic blood pressure by an average of 3–6 mmHg in overweight patients without pre-existing hypotension. This modest reduction is generally beneficial for people with elevated pressure, but patients with baseline low blood pressure face a different risk profile.
The blood pressure effect occurs through multiple mechanisms: improved insulin sensitivity reduces sympathetic nervous system activity, weight loss decreases overall cardiovascular strain, and direct GLP-1 receptor signaling in vascular tissue promotes mild vasodilation. For most patients, these changes improve heart health. However, someone already managing hypotension must weigh potential benefits against the risk of dropping pressure further into dangerous ranges.
Research published in cardiovascular journals shows that GLP-1 drugs do not typically cause severe hypotension in patients with normal baseline pressure. The risk becomes clinically meaningful primarily in people with diagnosed low blood pressure, particularly those taking blood pressure-lowering medications or managing conditions like orthostatic hypotension.
Blood Pressure Monitoring Before Starting Semaglutide
Before beginning semaglutide or any GLP-1 therapy, obtaining accurate resting and standing blood pressure measurements is essential. A single low reading does not always indicate pathological hypotension; dehydration, medication timing, or measurement error can cause temporary drops. Your prescribing clinician should review your entire blood pressure history and current medications to establish baseline risk.
PlexusDx requires a telehealth consultation with a licensed healthcare provider who reviews your medical history, current medications, and vital signs before treatment begins. This screening step identifies patients with symptomatic hypotension or those taking multiple antihypertensive drugs who need dose adjustments or closer monitoring. Patients with well-managed low blood pressure may still be candidates if their provider determines the benefit outweighs risk and a monitoring plan is in place.
Documentation of baseline blood pressure readings—taken at different times of day and in different positions—provides the clearest picture of your typical range. Bring this information to your consultation so PlexusDx providers can make personalized recommendations tailored to your cardiovascular profile.
Managing Hypotension Risk During GLP-1 Treatment
If you have low blood pressure and your provider approves semaglutide therapy, several practical steps reduce hypotension risk. Increasing sodium and fluid intake, avoiding rapid position changes (especially getting out of bed quickly), and wearing compression stockings can help maintain adequate blood volume and pressure. Regular blood pressure self-monitoring at home allows you and your provider to detect any concerning drops early.
Many patients taking semaglutide experience weight loss of 10–15% within 6 months, which typically reduces blood pressure overall. However, this benefit applies primarily to people with elevated pressure. Those with low baseline pressure may need to reduce or discontinue blood pressure medications as weight decreases, under their provider's guidance. PlexusDx telehealth providers monitor your progress and coordinate with your primary care physician to ensure medication adjustments happen safely.
Dose escalation should proceed gradually, starting with the lowest effective dose and increasing only if tolerated. The Precision Peptide Genetic Test available through PlexusDx can identify genetic variations in GLP1R, GIPR, and other pathways that predict how strongly you'll respond to semaglutide, helping providers optimize dosing from the start.
When to Avoid or Delay Semaglutide if You Have Low Blood Pressure
Certain situations warrant delaying or reconsidering GLP-1 therapy. Symptomatic hypotension—dizziness, fainting, blurred vision, or chest discomfort upon standing or exertion—indicates a blood pressure problem that needs stabilization before starting a medication that may lower it further. Untreated orthostatic hypotension (pressure drops significantly when standing) is a contraindication unless your provider can modify underlying causes first.
Patients taking three or more blood pressure medications, those with a history of syncope (fainting), or individuals with severe dehydration should have thorough cardiovascular evaluation before semaglutide therapy begins. Certain heart conditions, such as heart failure with reduced ejection fraction, may also increase hypotension risk with GLP-1 drugs. Your PlexusDx provider screens for these conditions and advises whether treatment is appropriate for your health status.
If you become pregnant, plan surgery, or develop a new condition affecting blood pressure regulation, inform your PlexusDx provider immediately. Temporary treatment pauses or dose adjustments may be necessary. Open communication between you, your PlexusDx telehealth team, and your primary care physician ensures safe, continuous care.
Semaglutide Pricing and Access at PlexusDx
PlexusDx offers compounded semaglutide injections from licensed 503A compounding pharmacies, starting at just $149 per month across all commitment tiers. Unlike many weight loss programs, PlexusDx does not charge membership fees, requires insurance, or tie pricing to dose levels—your dose may need to go up, but your price won't. This transparency makes personalized GLP-1 therapy accessible to patients nationwide.
PlexusDx serves all 50 states and accepts HSA and FSA funds, reducing out-of-pocket costs for eligible patients. The Precision Peptide Genetic Test ($99 add-on after your first month of treatment) analyzes 14 pathways and 150+ genetic insights to predict your individual response to semaglutide, helping PlexusDx providers fine-tune your treatment plan. Combined with ongoing telehealth monitoring, this personalized approach maximizes safety and results, especially for patients with complex medical histories like hypotension.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I take semaglutide if I have low blood pressure?
Semaglutide may be appropriate if your low blood pressure is mild, stable, and not causing symptoms, and your provider approves it. However, symptomatic hypotension or uncontrolled low blood pressure requires medical stabilization first. PlexusDx requires a telehealth consultation with a licensed provider who reviews your blood pressure history and medications to determine if treatment is safe for you.
How much does semaglutide lower blood pressure?
Clinical trials show semaglutide reduces systolic blood pressure by an average of 3–6 mmHg in overweight patients without baseline hypotension. The effect is typically modest and beneficial for people with high blood pressure, but patients with low baseline pressure need individual assessment. Your PlexusDx provider monitors your blood pressure response throughout treatment.
What should I do if I feel dizzy or faint while taking semaglutide?
Stop what you're doing, sit or lie down immediately, and contact your PlexusDx provider or seek emergency care if symptoms are severe or persistent. Dizziness during semaglutide treatment may signal a blood pressure drop or other issue requiring dose adjustment or medical investigation. Do not resume your dose until your provider evaluates you.
Will I need to stop my blood pressure medications if I start semaglutide?
Your existing blood pressure medications may need adjustment as you lose weight and semaglutide affects cardiovascular function, but only your provider can make that decision. PlexusDx coordinates with your primary care physician to ensure safe medication management. Never stop blood pressure medications on your own.
How does the Precision Peptide Genetic Test help with hypotension risk?
The Precision Peptide Genetic Test ($99) analyzes variants in GLP1R, GIPR, FTO, MC4R, and 46 other peptide-pathway genes that predict your individual response to semaglutide. Patients with genetic predispositions to stronger cardiovascular responses may benefit from careful dose titration and closer monitoring, helping PlexusDx providers personalize your treatment if you have low blood pressure.
What does semaglutide cost at PlexusDx, and is it covered by insurance?
Compounded semaglutide at PlexusDx starts at $149 per month, with no membership fees or insurance required. The price remains flat across all dose levels, and HSA/FSA funds are accepted. This makes personalized, monitored semaglutide therapy affordable and accessible for patients managing complex conditions like hypotension.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Integrating Metformin and Ozempic: A Comprehensive Guide for Type 2 Diabetes and Weight Management
How to Get the Weight Loss Drug Ozempic: Your Comprehensive Guide